To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Univax Biologics Inc.

Joseph Edelman of Prudential Securities raised Univax Biologics Inc. to "buy"

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE